The shares were picked up at an average price of Rs 4,680 apiece, taking the transaction value to Rs 300.32 crore.

The following block and bulk deals took place of both exchanges on February 21. Alkem LaboratoriesSamprada & Nanhamati Singh ...

SBI Mutual Fund bought additional shares of Alkem Laboratories for Rs 300 crore, increasing its stake to 2.7%. The shares, totaling 6.41 lakh, were acquired at Rs 4,680 each. This transaction saw the ...

Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of ...

At 09.16 am shares of Alkem Labs were trading at Rs 4,700.50 on the NSE. Alkem Labs shares are down over 16 percent ...

Mumbai: Cyber fraud has sent shockwaves through the pharma sector as Alkem Laboratories, a Mumbai-based pharmaceutical ...

Nuvama cuts Alkem Lab's target price by 3.5% amid slow acute business; read more for insights on future projections.

Alkem Laboratories has announced two strategic acquisitions totaling Rs 287 crores to strengthen its domestic market presence. The company will acquire Adroit Biomed for Rs 140 crore and Bombay Ortho ...

Based on the one-year price targets offered by 17 analysts, the average target price for Alkem Laboratories Ltd (NSE:ALKEM) is $5726.05 with a high estimate of $7225.00 and a low estimate of $4330.00.

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an ...

SBI Mutual Fund acquired 0.54% stake in Alkem Laboratories for Rs 300 crore through open market transaction, increasing its ...